Phase II clinical study on the efficacy and safety of the combination of trafluorouracil and antipyrimidine hydrochloride capsules in the treatment of metastatic colorectal cancer patients who have previously failed or intolerant to standard chemotherapy
Latest Information Update: 06 Jun 2025
At a glance
- Drugs Catequentinib (Primary) ; Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms ALTAS
Most Recent Events
- 06 Jun 2025 New trial record
- 30 Apr 2025 Results evaluating efficacy and safety of the combination of trafluorouracil and antipyrimidine tablets and anlotinib hydrochloride capsules presented at the 116th Annual Meeting of the American Association for Cancer Research.